Cognition TherapeuticsCGTX
13F holders, Q4 2024 (December 31)45holders +5
6new positions
2sold out
1famous investor
$0.70avg. 13F price*
At the end of Q4 2024, 45 institutions reported holding Cognition Therapeutics Inc. (CGTX) in their 13F filings, up 5 from Q3 2024. 6 opened new positions and 2 sold out. The largest holders were BIOS Capital Management, LP ($4.2M), Vanguard Group Inc. ($869K) and Sigma Planning Corp ($431K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cognition Therapeutics Inc.
- CUSIP
- 19243B102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $410K |
| Exits | 2 | $31K |
All 13F filers, Q3 2024 → Q4 2024: 1,205,719 shares bought and 378,858 shares sold, net +826,861 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| BIOS Capital Management, LP | 4.47% | — | 6,000,000 | $4.2M |
| Vanguard Group Inc. | 0.00% | Reduce -0.2% | 1,239,567 | $869K |
| Sigma Planning Corp | 0.01% | Add +211.6% | 614,490 | $431K |
| Voss Capital, LP | 0.03% | New | 500,000 | $351K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 500,000 | $351K |
| Geode Capital Management, LLC | 0.00% | Add +8.9% | 352,348 | $247K |
| American Financial Group Inc. | 0.07% | No change | 205,000 | $144K |
| CM Management, LLC | 0.13% | Reduce -20.0% | 200,000 | $140K |
| Kestra Advisory Services, LLC | 0.00% | Reduce -5.8% | 177,434 | $124K |
| BlackRock, Inc. | 0.00% | Add +0.3% | 156,039 | $109K |
| State Street Corp. | 0.00% | Add +94.2% | 121,850 | $85K |
| Acadian Asset Management LLC | 0.00% | Reduce -21.8% | 110,233 | $76K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 90,665 | $64K |
| Renaissance Technologies | 0.00% | Add +2.7% | 91,100 | $64K |
| Virtu Financial LLC | 0.00% | Add +40.1% | 80,180 | $56K |
| Two Sigma Investments, LP | 0.00% | Add +372.2% | 53,691 | $38K |
| Fca Corp. | 0.01% | No change | 51,471 | $36K |
| Circle Wealth Management, LLC | 0.00% | No change | 48,842 | $34K |
| Northern Trust Corp. | 0.00% | No change | 47,485 | $33K |
| Castle Wealth Management LLC | 0.01% | No change | 43,380 | $30K |
| UBS Group AG | 0.00% | Reduce -79.2% | 41,112 | $29K |
| SG Americas Securities, LLC | 0.00% | New | 37,108 | $26K |
| Bangor Savings Bank | 0.00% | No change | 34,019 | $24K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -58.4% | 31,874 | $22K |
| Tocqueville Asset Management L.P. | 0.00% | Add +21.3% | 28,500 | $20K |
| Northeast Financial Consultants Inc | 0.00% | No change | 24,500 | $17K |
| Bryn Mawr Trust Advisors, LLC | 0.00% | New | 23,337 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +90.8% | 20,970 | $15K |
| HighTower Advisors, LLC | 0.00% | Reduce -15.2% | 19,462 | $14K |
| Osaic Holdings, Inc. | 0.00% | Add +955.6% | 19,000 | $13K |
| Raymond James Financial Inc. | 0.00% | — | 17,500 | $12K |
| Morgan Stanley | 0.00% | Add +1587.3% | 16,873 | $12K |
| Mercer Global Advisors Inc. | 0.00% | No change | 16,051 | $11K |
| Bessemer Group Inc. | 0.00% | No change | 13,797 | $10K |
| Two Sigma Securities, LLC | 0.00% | New | 13,741 | $10K |
| Smith Anglin Financial, LLC | 0.00% | No change | 12,000 | $8K |
| Jane Street Group, LLC | 0.00% | Reduce -55.8% | 10,040 | $7K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 10,000 | $7K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 5,867 | $4K |
| Bank of America Corp. | 0.00% | Add +0.2% | 5,290 | $4K |
| Bray Capital Advisors | 0.00% | No change | 2,250 | $2K |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $701 |
| MAI Capital Management | 0.00% | New | 200 | $141 |
| JPMorgan Chase & Co. | 0.00% | Reduce -3.9% | 75 | $53 |
| FMR LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CGTX's weight in each manager's 13F, not the share of Cognition Therapeutics Inc. the manager owns.